BioNano Genomics Inc BNGO shares are trading higher by 19.5% at $7.36 Monday on continued strength following last week’s publication of DNA replication data, a fundamental process of cell growth implicated in cancer that was previously hard to study in human genomes.
Bionano Genomics is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
